04.04.19

Oxurion NV Announces Full Enrollment of Its Phase 2 Trial Evaluating Combination of Anti-PlGF (THR-317) and Anti-VEGF (Ranibizumab) for the Treatment of DME

Source: Oxurion NV

03.12.19

Cataract-Surgery Adjuncts Improve Vision in Diabetic Macular Edema

Source: Reuters

03.04.19

Roche/Genentech Study Shows First-Time Proof That AI Can Detect Severity of DME

Source: Genentech

02.08.19

Glycemic Control Tied to Better Outcome of Anti-VEGF Therapy for Diabetic Macular Edema

Source: Reuters

01.04.19

Oculis Raises $15.7 Million to Advance Development of Novel Topical Treatments for Ophthalmic Diseases

Source: Oculis

12.21.18

Kodiak Sciences Announces Completion of 12-Week Phase 1a Study of KSI-301 in Patients with DME

Source: Kodiak Sciences

11.13.18

AsclepiX Therapeutics Raises $5 Million to Advance Therapies in AMD and DME

Source: AsclepiX Therapeutics

11.02.18

SemaThera Board Names Garth Cumberlidge as President & CEO

Source: SemaThera

10.03.18

Fluocinolone Acetonide Implant Effective for Refractory Diabetic Macular Edema

Source: Reuters

09.18.18

Allergan Announces New Partnership With the International Diabetes Federation

Source: Allergan

View more stories